Olink Holding AB (publ) OLK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:45 PM EDT
13.49quote price arrow up+0.43 (+3.29%)
Volume
96,870
52 week range
8.39 - 35.00
Loading...
  • Open12.89
  • Day High14.03
  • Day Low12.65
  • Prev Close13.06
  • 52 Week High35.00
  • 52 Week High Date11/05/21
  • 52 Week Low8.39
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap1.607B
  • Shares Out119.10M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-26.98

KEY STATS

  • Open12.89
  • Day High14.03
  • Day Low12.65
  • Prev Close13.06
  • 52 Week High35.00
  • 52 Week High Date11/05/21
  • 52 Week Low8.39
  • 52 Week Low Date06/16/22
  • Market Cap1.607B
  • Shares Out119.10M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-26.98

RATIOS/PROFITABILITY

  • EPS (TTM)-0.25
  • P/E (TTM)-52.92
  • Fwd P/E (NTM)-44.97
  • EBITDA (TTM)-33.071M
  • ROE (TTM)-6.54%
  • Revenue (TTM)113.85M
  • Gross Margin (TTM)59.82%
  • Net Margin (TTM)-26.73%
  • Debt To Equity (MRQ)2.17%

EVENTS

  • Earnings Date11/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Olink Holding AB (publ)

 

Profile

MORE
Olink Holding AB (publ) is a Sweden-based company engaged in the marketing and sales of biotechnological products and services. The Company offers a technique to identify actionable biomarkers, with a focus on the human plasma proteome. The Company operates in Sweden and the USA.
Jon Hindar
Non-Executive Independent Chairman of the Board
Jon Heimer
Chief Executive Officer, Director
Fredrik Netzel
Chief Operating Officer
Oskar Hjelm
Chief Financial Officer
Linda Ramirez-Eaves Esq.
General Counsel
Address
c/o OLINK PROTEOMICS
Uppsala Science Park
Uppsala
751 83
Sweden

Top Peers

SYMBOLLASTCHG%CHG
SILK
Silk Road Medical Inc
47.78+3.93+8.96%
TMCI
Treace Medical Concepts Inc
23.15+0.76+3.39%
PRCT
Procept Biorobotics Corp
40.77+0.78+1.94%
CTKB
Cytek Biosciences Inc
14.13+1.39+10.91%
ESTA
Establishment Labs Holdings Inc
53.71+2.87+5.65%